Recommendations for Prevention and Control of Influenza in Children, 2022-2023

Area of Science:

• Pediatrics
• Infectious Diseases
• Vaccinology

Background:

• Influenza poses a significant health risk to children, contributing to morbidity and mortality.
• Co-circulation of respiratory viruses, including SARS-CoV-2, underscores the importance of influenza prevention.
• Annual influenza vaccination is a key strategy for protecting pediatric populations and the community.

Purpose of the Study:

• To provide updated recommendations for influenza vaccine and antiviral use in children for the 2022-2023 season.
• To summarize recent influenza seasons, pediatric morbidity/mortality, vaccine effectiveness, and coverage rates.
• To offer guidance on vaccine storage, administration, implementation, and strategies for promoting uptake.

Main Methods:

• Review of recent influenza season data, including morbidity, mortality, and vaccine effectiveness.
• Analysis of pediatric influenza immunization rates and vaccine coverage.
• Compilation of updated information on available influenza vaccines and recommendations.

Main Results:

• Influenza vaccination is recommended for all children 6 months and older without contraindications.
• Vaccination is crucial for reducing disease burden, hospitalizations, and mortality in children.
• Updated guidance addresses vaccine types, administration, special populations (pregnant/breastfeeding), and managing allergic reactions.

Conclusions:

• Annual influenza vaccination is a safe and effective measure for pediatric influenza prevention.
• Vaccination contributes to broader public health by reducing respiratory illness burden during periods of viral co-circulation.
• Comprehensive guidance supports healthcare providers in implementing effective influenza prevention and treatment strategies for children.